Does BETASERON Cause Mobility decreased? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Mobility decreased have been filed in association with BETASERON. This represents 1.2% of all adverse event reports for BETASERON.
7
Reports of Mobility decreased with BETASERON
1.2%
of all BETASERON reports
2
Deaths
3
Hospitalizations
How Dangerous Is Mobility decreased From BETASERON?
Of the 7 reports, 2 (28.6%) resulted in death, 3 (42.9%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BETASERON. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does BETASERON Cause?
Influenza like illness (65)
Injection site pain (43)
Drug ineffective (41)
Multiple sclerosis relapse (41)
Multiple sclerosis (38)
Injection site erythema (35)
Depression (33)
Fatigue (29)
Drug dose omission (22)
Injection site bruising (22)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which BETASERON Alternatives Have Lower Mobility decreased Risk?
BETASERON vs BETAXOLOL
BETASERON vs BETHANECHOL
BETASERON vs BEVACIZUMAB
BETASERON vs BEVACIZUMAB-AWWB
BETASERON vs BEVACIZUMAB-BVZR